肝脏丰富的长非编码RNA FAM99A通过负调节蛋白质合成来抑制瘤发生
Nima Sarfaraz1, Ranjit Kaur1, Sky Harper2
1Graduate Program in Molecular and Cell Biology and Genetics, Graduate School of Biomedical Sciences and Professional Studies, College of Medicine, Drexel University, Philadelphia, Pennsylvania, USA.
Journal of molecular biology
|January 25, 2026
概括
研究人员确定了FAM99A,一种肝脏特异性的长非编码RNA (lncRNA),通过抑制蛋白质合成来抑制肝癌. 它的下调与糟糕的结果相关,表明作为生物标志物和治疗点的潜力.
科学领域:
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
- 在瘤学瘤学.
背景情况:
- 原发性肝癌对全球健康构成重大挑战,其先进治疗选择有限.
- 长非编码RNAs (lncRNAs) 正在成为肝病进展的关键参与者.
研究的目的:
- 为了研究肝脏丰富的lncRNA FAM99A在肝癌发生中的作用.
- 探索FAM99A作为诊断生物标志物和肝癌治疗点的潜力.
主要方法:
- 在肝癌组织和细胞系中识别和描述FAM99A的表达.
- 功能性分析包括定独立增长和全球转化率测量.
- 转录组分析,质谱和临床数据的相关性.
主要成果:
- 在肝脏恶性瘤中,FAM99A显著下调,与不良的临床结果相关.
- 过度表达FAM99A会抑制癌细胞的生长,并减少全球蛋白质合成.
- FAM99A与翻译机械组件直接相互作用,并与患者的核糖体蛋白基因呈反相关性.
- 乙型肝炎病毒可能导致FAM99A下调.
结论:
- 通过调节翻译,FAM99A在肝脏中起到瘤抑制作用.
- FAM99A是一种有前途的生物标志物,也是肝癌的潜在治疗剂.
相关概念视频
Negative Regulator Molecules
38.3K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.3K
Transfer RNA Synthesis
13.3K
One of the unique features of tRNA is the presence of modified bases. In some tRNAs, modified bases account for nearly 20% of the total bases in the molecule. Altogether, these unusual bases protect the tRNA from enzymatic degradation by RNases.
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
13.3K
Transfer RNA Synthesis
3.6K
3.6K
Ribosomal RNA Synthesis
14.7K
Ribosome synthesis is a highly complex and coordinated process involving more than 200 assembly factors. The synthesis and processing of ribosomal components occurs not only in the nucleolus but also in the nucleoplasm and the cytoplasm of eukaryotic cells.
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
14.7K
Ribosomal RNA Synthesis
4.3K
4.3K
lncRNA - Long Non-coding RNAs
9.8K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K


